FDA Brief

Warning letters Drugs

FDA warning letter to

eDrugstore

High riskIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warns eDrugstore over claims that compounded tirzepatide is FDA-approved, making drugs misbranded (falsely promoted).

What happened

In August 2025, FDA reviewed the website https://www.edrugstore.com and found it offered compounded drug products, including tirzepatide. FDA cited website claims such as “FDA-Approved Active” and a guarantee that all Tirzepatide medications are genuine, FDA-approved formulations. FDA says compounded drugs are not FDA-approved, so these claims are false or misleading and make the products “misbranded” (falsely or misleadingly labeled).

What FDA found

  1. Website labeling claims falsely suggest the compounded tirzepatide is FDA-approved, which makes the drug misbranded.

    FDCA section 502(a) [21 U.S.C. § 352(a)]
  2. Advertising and promotion of the compounded drug are false or misleading because they imply it is the same as an FDA-approved product such as Zepbound.

    FDCA section 502(bb) [21 U.S.C. § 352(bb)]
  3. Introducing or delivering the misbranded drugs into interstate commerce is a prohibited act.

    FDCA section 301(a) [21 U.S.C. § 331(a)]
  4. Receiving misbranded drugs in interstate commerce, or delivering them, is also a prohibited act.

    FDCA section 301(c) [21 U.S.C. § 331(c)]

What FDA wants

FDA tells eDrugstore to take immediate action to stop using the misleading claims and to send a written response within 15 working days describing the steps taken, how it will prevent recurrence, and supporting documentation.

Who should pay attention

  • online pharmacies and telehealth companies selling compounded drugs
  • marketers of compounded tirzepatide
  • platforms that host or promote drug ads

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low